Thymalfasin to Boost COVID-19 Vaccine Response in Older Adults
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This trial tests whether a drug called thymalfasin (thymosin alpha 1) can help older adults (65+) get a stronger immune response from their COVID-19 booster shot. It may be especially helpful for those whose immune systems have weakened with age.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 65 or older.
- Scheduled to receive a COVID-19 mRNA booster.
- Not severely immunocompromised (e.g., no active cancer treatment, no organ transplant, no HIV with low CD4).
- No history of heart inflammation (myocarditis) or severe allergic reaction to vaccines.
- No significant kidney or liver disease.
- No recent COVID-19 infection or vaccination (within 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests a booster vaccine made from a three-part COVID-19 protein (aimed at XBB, BA.5, and Delta) to see how well it works and is tolerated. It may help adults who are due for a COVID-19 booster, including people with certain health conditions, depending on screening results.
This Phase 2 study tests a booster vaccine made from a COVID-19 protein (XBB + prototype) to help your immune system respond better. You may be able to join if you’re an adult who is due for a booster and meets health and safety screening checks.
This study tests whether a medication called rapamycin (sirolimus) can help improve your body's response to flu and RSV vaccines. You have end-stage kidney disease and receive dialysis three times a week, and the researchers want to see if this approach keeps you safer from these infections.
This study looks at how well a COVID-19 booster works in adults who need long-term medicines that lower immune response. It aims to see whether immunosuppressed people benefit from booster vaccination safely.
This trial tests a combination of two medicines—thymalfasin and IL-2—to see if they can help raise low white blood cell counts (lymphocytes) in people with blood cancers. If you have low lymphocytes from your cancer or its treatment, this study may offer a way to boost your immune system.
This study tests whether taking oral supplements can improve how well your body responds to the flu vaccine. It may help older adults get better protection from the flu shot.
Hear when a new Vaccine Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.